Loading organizations...
Loading organizations...
Developing monoclonal antibodies for cancer immune therapy.
Nectin Therapeutics has raised $30.4M across 2 funding rounds.
Nectin Therapeutics has raised $30.4M in total across 2 funding rounds.
Nectin Therapeutics has raised $30.4M in total across 2 funding rounds.
Nectin Therapeutics's investors include IBF, Peregrine Ventures, Cancer Focus Fund.
Nectin Therapeutics has raised $30.4M across 2 funding rounds. Most recently, it raised $25.0M Series A Extension in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 30, 2022 | $25.0M Series A Extension | IBF, Peregrine Ventures | |
| Mar 9, 2022 | $5.4M Other Equity | Cancer Focus Fund |